# Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels

> **NCT04495608** · PHASE2 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 56 (actual)

## Conditions studied

- Nephrolithiasis
- Nephrocalcinosis
- Hypercalciuria

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04495608
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-13
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04495608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04495608, "Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04495608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*